Literature DB >> 8113255

Prediction of collapse with magnetic resonance imaging of avascular necrosis of the femoral head.

K Shimizu1, H Moriya, T Akita, M Sakamoto, T Suguro.   

Abstract

In order to predict the probability of collapse of a femoral head in which there is avascular necrosis, we used magnetic resonance imaging to evaluate sixty-six hips (fifty patients) in which avascular necrosis was in the early stages and in which collapse of the head was not yet visible. The hips were followed radiographically for an average of forty-nine months (range, sixteen to eighty-four months), and with magnetic resonance imaging for an average of forty-four months (range, twelve to seventy-three months). Twenty-one (32 per cent) of the femoral heads had collapsed by thirty-two months. Of the twenty-three femoral heads in which necrosis involved at least one-fourth of the diameter of the head and encompassed at least two-thirds of the major weight-bearing area, seventeen (74 per cent) had collapsed by thirty-two months.

Entities:  

Mesh:

Year:  1994        PMID: 8113255     DOI: 10.2106/00004623-199402000-00007

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  32 in total

1.  Untreated asymptomatic hips in patients with osteonecrosis of the femoral head.

Authors:  Byung-Woo Min; Kwang-Soon Song; Chul-Hyun Cho; Sung-Moon Lee; Kyung-Jae Lee
Journal:  Clin Orthop Relat Res       Date:  2008-03-08       Impact factor: 4.176

2.  Transtrochanteric rotational osteotomy for nontraumatic osteonecrosis of the femoral head in young adults.

Authors:  Sandeep Biswal; Sunit Hazra; Ho Hyun Yun; Chang Yong Hur; Won Yong Shon
Journal:  Clin Orthop Relat Res       Date:  2009-01-14       Impact factor: 4.176

3.  The natural progression of shoulder osteonecrosis related to corticosteroid treatment.

Authors:  Philippe Hernigou; Charles-Henri Flouzat-Lachaniette; Xavier Roussignol; Alexandre Poignard
Journal:  Clin Orthop Relat Res       Date:  2009-09-18       Impact factor: 4.176

Review 4.  MRI-detected bone marrow changes within 3 weeks after initiation of high-dose corticosteroid therapy: a possible change preceding the subsequent appearance of low-intensity band in femoral head osteonecrosis.

Authors:  Yusuke Kubo; Takuaki Yamamoto; Goro Motomura; Nobuaki Tsukamoto; Kazuyuki Karasuyama; Kazuhiko Sonoda; Hiroyuki Hatanaka; Takeshi Utsunomiya; Yukihide Iwamoto
Journal:  Rheumatol Int       Date:  2015-08-22       Impact factor: 2.631

5.  Ischemic necrosis of the entire femoral head and rapidly destructive hip disease: potential causative relationship.

Authors:  K N Ryu; E J Kim; M C Yoo; Y K Park; D J Sartoris; D Resnick
Journal:  Skeletal Radiol       Date:  1997-03       Impact factor: 2.199

6.  Bone marrow oedema on MR imaging indicates ARCO stage 3 disease in patients with AVN of the femoral head.

Authors:  Reinhard Meier; Tobias M Kraus; Christoph Schaeffeler; Sebastian Torka; Anna Melissa Schlitter; Katja Specht; Bernhard Haller; Simone Waldt; Hans Rechl; Ernst J Rummeny; Klaus Woertler
Journal:  Eur Radiol       Date:  2014-05-28       Impact factor: 5.315

7.  Osteonecrosis of femoral head: Treatment by core decompression and vascular pedicle grafting.

Authors:  Sudhir Babhulkar
Journal:  Indian J Orthop       Date:  2009-01       Impact factor: 1.251

8.  Pitavastatin may reduce risk of steroid-induced osteonecrosis in rabbits: a preliminary histological study.

Authors:  Kenjiro Nishida; Takuaki Yamamoto; Goro Motomura; Seiya Jingushi; Yukihide Iwamoto
Journal:  Clin Orthop Relat Res       Date:  2008-03-19       Impact factor: 4.176

Review 9.  The role of imaging in diagnosis and management of femoral head avascular necrosis.

Authors:  Guglielmo Manenti; Simone Altobelli; Luca Pugliese; Umberto Tarantino
Journal:  Clin Cases Miner Bone Metab       Date:  2016-04-07

10.  Lesion size changes in osteonecrosis of the femoral head: a long-term prospective study using MRI.

Authors:  Feng-chao Zhao; Zi-rong Li; Nian-fei Zhang; Bai-liang Wang; Wei Sun; Li-ming Cheng; Zhao-hui Liu
Journal:  Int Orthop       Date:  2009-06-17       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.